Correction: Hydrogen sulfide-releasing cyclooxygenase inhibitor ATB-346 enhances motor function and reduces cortical lesion volume following traumatic brain injury in mice.

This correction notice from the Journal of Neuroinflammation addresses an error in the magnification of Figure 7 in an article titled "Hydrogen sulfide-releasing cyclooxygenase inhibitor ATB-346 enhances motor function and reduces cortical lesion volume following traumatic brain injury in mice." The magnifications of panels B and C were switched, and the revised Figure 7 is provided in the correction. The figure shows histological examination of brain sections after 24 hours, demonstrating brain tissue injury and inflammatory cell infiltration in TBI mice and TBZ-treated mice. ATB-346 treatment reduced the degree of brain injury and inflammatory cell infiltration. The correction is authored by Michela Campolo, Emanuela Esposito, Akbar Ahmad, Rosanna Di Paola, Irene Paterniti, Marika Cordaro, Giuseppe Bruschetta, John L. Wallace, and Salvatore Cuzzocrea. [Extracted from the article]